Innovation Pharmaceuticals Inc (IPIX)

[Amatuer17]

Here is very similar case

NASH-CX - no other drug has shown any results - this was 1st in class drug. Co applied for BTD, set End of P2 meeting.
BTD was rejected, co is going ahead with P3 based FDA inputs and guidance

Galectin Therapeutics Proceeds to Phase 3 Development of GR-MD-02 for NASH Cirrhosis Following FDA Meeting $GALT

https://seekingalpha.com/pr/17162133